Cite

    K. Hørslev-Petersen et al.. “FRI0148 Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis - 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA).” Annals of the rheumatic diseases, vol. 71, n.d., pp. 360–361. http://access.bl.uk/ark:/81055/vdc_100137793076.0x00005c